Ionis Pharmaceuticals (IONS) Raw Materials (2009 - 2025)

Ionis Pharmaceuticals' Raw Materials history runs 17 years deep, the most recent figure standing at $640000.0 for Q1 2025.

• In Q1 2025, Raw Materials fell 97.34% year-over-year to $640000.0; the TTM figure through Mar 2025 stood at $640000.0 (down 97.34% YoY), while the FY2024 annual figure was $5.6 million, up 207.02% from the prior year.
• Raw Materials was $640000.0 for Q1 2025 at Ionis Pharmaceuticals, down from $5.6 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $24.6 million in Q2 2024 to a low of $640000.0 in Q1 2025.
• Historically, Raw Materials has averaged $17.0 million across 5 years, with a median of $18.6 million in 2021.
• The sharpest annual moves came in 2024 and 2025: Raw Materials surged 207.02% in 2024, then slumped 97.34% in 2025.
• A 5-year view of Raw Materials shows it stood at $18.6 million in 2021, then climbed by 5.97% to $19.8 million in 2022, then slumped by 90.84% to $1.8 million in 2023, then soared by 207.02% to $5.6 million in 2024, then plunged by 88.48% to $640000.0 in 2025.
• The last three Raw Materials figures came in at $640000.0 (Q1 2025), $5.6 million (Q4 2024), and $21.7 million (Q3 2024), per Business Quant data.